RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Attitudes and experiential factors associated with completion of mt-sDNA test kit for colorectal cancer screening
Finney Rutten, L. J., Zhu, X., Treiman, K., Madson, G., Southwell, B., Helmueller, L., Alam, S., Gates, C., & Squiers, L. (2023). Attitudes and experiential factors associated with completion of mt-sDNA test kit for colorectal cancer screening. Journal of patient experience, 10, Article 23743735231213765. https://doi.org/10.1177/23743735231213765
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the United States. Despite the availability of multiple screening options, CRC screening is underutilized. We conducted a survey of patients (n = 2973) who were prescribed the multi-target stool DNA (mt-sDNA) screening test (commercialized as Cologuard
® and manufactured by Exact Sciences Corporation) to understand attitudes and experiences that influence test completion and likelihood of future test completion. Using exploratory factor analyses, we developed three scales: Perceived Effectiveness, Perceived Ease of Use, and Perceived Comfort.
